To determine whether immune scMEP marker expression correlated with ex vivo melanoma antigen-specific T-cell responses, we observed that CD11c and PD-L1 were significantly elevated in mDCs from patients with positive CD8 and combined CD8 + CD4 T cells responses (Fig. 5D). This evidence concerns the gene CD8A and melanoma.